Knollwood Investment Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Knollwood Investment Advisory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,173	Closed	-$663K	–	362
2025 Q1	$663K	Hold	8,173	–	–	0.07%	225
2024 Q4	$736K	Hold	8,173	–	–	0.08%	223
2024 Q3	$807K	Hold	8,173	–	–	0.09%	223
2024 Q2	$758K	Sell	8,173 -5,500	-40%	-$493K	0.08%	219
2024 Q1	$1.3M	Hold	13,673	–	–	0.23%	82
2023 Q4	$1.22M	Hold	13,673	–	–	0.25%	82
2023 Q3	$998K	Hold	13,673	–	–	0.47%	57
2023 Q2	$1.14M	Hold	13,673	–	–	0.38%	70
2023 Q1	$1.04M	Hold	13,673	–	–	0.2%	76
2022 Q4	$1.13M	Buy	+13,673	New	+$1.11M	0.44%	58

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Knollwood Investment Advisory's XBI Position: Q2 2025 in Review

Knollwood Investment Advisory sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 8,173 shares — an estimated $663K sold.

Knollwood Investment Advisory first reported a position in XBI in Q4 2022 and held it in 10 quarters. The position peaked at $1.3M in Q1 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Knollwood Investment Advisory reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Knollwood Investment Advisory sold 8,173 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $663K.
Knollwood Investment Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 10 quarters.
Knollwood Investment Advisory's State Street SPDR S&P Biotech ETF position peaked at $1.3M in Q1 2024.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Knollwood Investment Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.